mainstream

Infrastructure for Medication Therapy Management (MTM) Identification

ML model that identifies patients who would benefit from comprehensive medication reviews, optimizing pharmacist time and improving medication safety.

Last updated: February 2026Data current as of: February 2026

Analysis based on CMC Framework: 730 capabilities, 560+ vendors, 7 industries.

T2·Workflow-level automation

Key Finding

Medication Therapy Management (MTM) Identification requires CMC Level 3 Formality for successful deployment. The typical pharmacy operations organization in Healthcare faces gaps in 0 of 6 infrastructure dimensions.

Structural Coherence Requirements

The structural coherence levels needed to deploy this capability.

Requirements are analytical estimates based on infrastructure analysis. Actual needs may vary by vendor and implementation.

Formality
L3
Capture
L3
Structure
L3
Accessibility
L3
Maintenance
L2
Integration
L3

Why These Levels

The reasoning behind each dimension requirement.

Formality: L3

MTM identification requires explicitly documented eligibility criteria—CMS and payer-specific thresholds for polypharmacy count, chronic condition combinations, and annual drug cost minimums—to be current and findable. These criteria are not tribal knowledge; they are regulatory requirements that change with annual CMS rule updates. The ML cannot generate compliant MTM-eligible patient lists without documented, current eligibility logic that maps to specific payer contract terms and program requirements accessible to program administrators.

Capture: L3

MTM identification requires systematic capture of medication fill history, adherence patterns, diagnosis codes, and hospitalization events through pharmacy systems, EHR, and claims data. CPOE, eMAR, and pharmacy dispensing systems log medication events through defined workflows requiring patient ID, medication, fill date, and dispensed quantity. This systematic capture creates the longitudinal medication and clinical history the ML needs to identify polypharmacy patients and detect non-adherence patterns from refill gaps.

Structure: L3

MTM candidate identification requires consistent schema: patient ID, active medication list with RxNorm codes, diagnosis codes, refill dates, days supply, proportion of days covered (PDC), and eligibility flags by payer. Standardized drug codes (RxNorm, NDC) and diagnosis taxonomies (ICD-10) provide structured identifiers. The ML needs all patient medication records to share these defined fields to compute polypharmacy counts, PDC scores, and payer-specific eligibility criteria reliably across the enrolled population.

Accessibility: L3

MTM identification requires the ML to access patient medication histories, diagnosis data, refill records, hospitalization events, and payer eligibility files. Existing pharmacy-EHR integration and API connections to drug databases provide access to internal medication and clinical data. The system can query active medication lists, recent fill history, and chronic condition diagnoses through connected systems to generate MTM candidate lists without manual data extraction for routine program operations.

Maintenance: L2

MTM eligibility criteria are updated on scheduled annual cycles aligned to CMS rule updates and payer contract renewals. Medication fill history and adherence data are maintained through ongoing systematic capture. For the identification model, scheduled updates to eligibility parameters are sufficient since CMS program criteria change predictably on annual cycles. Between updates, the eligibility logic is stable, and the ML operates on continuously updated patient data to identify current program candidates.

Integration: L3

MTM identification requires integration between pharmacy management, EHR clinical data, claims data for adherence metrics, and outreach management systems. Existing closed-loop medication use integration—EHR to pharmacy to ADC to eMAR—with emerging payer data connections provides API-based connectivity for the core identification workflow. The ML can access medication, diagnosis, and hospitalization data through connected systems to generate prioritized MTM candidate lists and route outreach recommendations to care coordinators.

What Must Be In Place

Concrete structural preconditions — what must exist before this capability operates reliably.

Primary Structural Lever

How explicitly business rules and processes are documented

The structural lever that most constrains deployment of this capability.

How explicitly business rules and processes are documented

  • Standardized, machine-readable eligibility criteria for MTM qualification codified as queryable rule sets, including chronic disease thresholds, polypharmacy counts, and payer-specific conditions

Whether operational knowledge is systematically recorded

  • Systematic capture of medication fill history, refill adherence events, and dispensing gaps into structured longitudinal records with defined schemas

How data is organized into queryable, relational formats

  • Formal taxonomy of chronic disease classifications, medication therapy categories, and intervention types with validated cross-references to diagnosis codes

Whether systems expose data through programmatic interfaces

  • Self-service access layer exposing patient medication profiles and eligibility signals to the identification model via role-based query interfaces

Whether systems share data bidirectionally

  • Standard API connections to pharmacy dispensing systems, claims databases, and EHR medication lists to feed the identification pipeline

How frequently and reliably information is kept current

  • Scheduled review cycle for eligibility rule currency, covering payer contract updates and clinical guideline changes affecting MTM qualification criteria

Common Misdiagnosis

Teams invest in predictive model sophistication while eligibility criteria remain embedded in pharmacist tribal knowledge — the model cannot score patients it cannot formally define as candidates.

Recommended Sequence

Start with formalising eligibility criteria into machine-readable rule sets before C or I, since the identification model requires explicit qualification logic before any data capture investment pays off.

Gap from Pharmacy Operations Capacity Profile

How the typical pharmacy operations function compares to what this capability requires.

Pharmacy Operations Capacity Profile
Required Capacity
Formality
L4
L3
READY
Capture
L4
L3
READY
Structure
L4
L3
READY
Accessibility
L3
L3
READY
Maintenance
L3
L2
READY
Integration
L3
L3
READY

More in Pharmacy Operations

Frequently Asked Questions

What infrastructure does Medication Therapy Management (MTM) Identification need?

Medication Therapy Management (MTM) Identification requires the following CMC levels: Formality L3, Capture L3, Structure L3, Accessibility L3, Maintenance L2, Integration L3. These represent minimum organizational infrastructure for successful deployment.

Which industries are ready for Medication Therapy Management (MTM) Identification?

Based on CMC analysis, the typical Healthcare pharmacy operations organization is not structurally blocked from deploying Medication Therapy Management (MTM) Identification. All dimensions are within reach.

Ready to Deploy Medication Therapy Management (MTM) Identification?

Check what your infrastructure can support. Add to your path and build your roadmap.